Trial
NCT03738800
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Mayne Pharma International Pty Ltd
Collaborators
—
Condition
Lamellar Ichthyosis
Intervention
CD5789 Cream 200 µg/g
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-14